8
Participants
Start Date
March 21, 2017
Primary Completion Date
June 30, 2020
Study Completion Date
December 31, 2020
Probenecid
This is a cross-over pilot study where participants will receive both the study medication (probenecid), as well as a placebo to see if the study medication improves magnetic resonance parameters of systolic and diastolic dysfunction that occurs in the Fontan population.
Placebo
placebo
Cincinnati Childrens Hospital Medical Center, Cincinnati
American Heart Association
OTHER
Children's Hospital Medical Center, Cincinnati
OTHER